Mark B Geyer

30PUBLICATIONS
133CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentForensic psychologyGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Jun 18, 2026
Outcomes of Adolescents and Young Adults with AML Treated on Pediatric vs Adult Protocols.

|Apr 23, 2026
Donor T cells on double duty: VCAR33 for AML after transplant.

|Apr 10, 2026
Overcoming MEN1-mediated resistance with menin inhibitor switching in KMT2A-rearranged acute myeloid leukemia.

Kuo-Kai Chin, Maher Abdul-Hay, Mihir Shukla

|Dec 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Joseph M Rocco, Joseph H Oved, Rikita J Patel

|Dec 06, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.

Kuo-Kai Chin, Brian J Ball, Yasmin Abaza

Pageof 5

Frequent Collaborators

7 joint publications

Andriy Derkach

6 joint publications

Wenbin Xiao

5 joint publications

Ahmet Dogan

4 joint publications

Jacob L Glass